TipRanks
Go Ultimate55% OFF

MedSmart Group (MSGP) Ratios

MedSmart Group Ratios

MSGP's free cash flow for Q3 2022 was $-23.75K. For the 2022 fiscal year, MSGP's free cash flow was increased by $0.00 and operating cash flow was $-23.75K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 20Dec 19Dec 18Dec 17
Liquidity Ratios
Current Ratio0.280.010.030.04
Quick Ratio0.280.010.020.03
Cash Ratio0.280.000.020.03
Solvency Ratio-0.060.134.560.27
Operating Cash Flow Ratio-0.68-0.021.350.10
Short-Term Operating Cash Flow Coverage-0.99-0.094.410.31
Net Current Asset Value$ -799.05K$ -392.33K$ -285.03K$ -1.64M
Leverage Ratios
Debt-to-Assets Ratio1.0531.9310.357.53
Debt-to-Equity Ratio-4.48-0.18-0.32-0.33
Debt-to-Capital Ratio1.29-0.22-0.46-0.49
Long-Term Debt-to-Capital Ratio-0.400.000.000.00
Financial Leverage Ratio-4.28-0.01-0.03-0.04
Debt Service Coverage Ratio-0.100.812.280.89
Interest Coverage Ratio-9.54-1.940.003.12
Debt to Market Cap1.980.110.120.38
Interest Debt Per Share0.880.090.060.46
Net Debt to EBITDA-19.170.790.410.84
Profitability Margins
Gross Profit Margin0.00%22.24%28.16%46.40%
EBIT Margin0.00%-1.90%25.29%21.18%
EBITDA Margin0.00%1.99%3.87%22.77%
Operating Profit Margin0.00%-1.69%3.87%13.75%
Pretax Profit Margin0.00%-2.77%25.29%16.77%
Net Profit Margin0.00%-2.77%25.29%16.77%
Continuous Operations Profit Margin0.00%-2.77%25.29%16.77%
Net Income Per EBT100.00%100.00%100.00%100.00%
EBT Per EBIT33.39%164.09%653.55%121.95%
Return on Assets (ROA)-7.55%-5565.69%15394.34%593.65%
Return on Equity (ROE)32.28%31.10%-469.78%-26.03%
Return on Capital Employed (ROCE)-56.55%18.95%-71.88%-21.34%
Return on Invested Capital (ROIC)-27.77%23.07%-105.05%-31.86%
Return on Tangible Assets-7.55%-5565.69%15394.34%593.65%
Earnings Yield-31.12%-19.52%183.05%30.20%
Efficiency Ratios
Receivables Turnover0.000.000.000.00
Payables Turnover0.5227.17126.805.66
Inventory Turnover0.000.001883.17159.53
Fixed Asset Turnover0.000.000.000.00
Asset Turnover0.002011.86608.7635.40
Working Capital Turnover Ratio0.00-13.02-5.50-1.38
Cash Conversion Cycle-703.76-13.44-2.68-62.25
Days of Sales Outstanding0.000.000.000.00
Days of Inventory Outstanding0.000.000.192.29
Days of Payables Outstanding703.7613.442.8864.54
Operating Cycle0.000.000.192.29
Cash Flow Ratios
Operating Cash Flow Per Share-0.34-0.010.270.12
Free Cash Flow Per Share-0.40-0.010.270.12
Dividend Paid and CapEx Coverage Ratio-5.670.000.000.00
Capital Expenditure Coverage Ratio-5.670.000.000.00
Operating Cash Flow Coverage Ratio-0.39-0.094.410.31
Operating Cash Flow to Sales Ratio0.00-0.000.070.06
Free Cash Flow Yield-198.31%-1.04%54.23%11.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-3.21-5.120.553.31
Price-to-Sales (P/S) Ratio0.000.140.140.56
Price-to-Book (P/B) Ratio-1.04-1.59-2.57-0.86
Price-to-Free Cash Flow (P/FCF) Ratio-0.50-96.021.848.56
Price-to-Operating Cash Flow Ratio-0.59-96.021.848.56
Price-to-Earnings Growth (PEG) Ratio0.090.050.000.00
Enterprise Value Multiple-24.477.903.983.28
Enterprise Value841.95K694.83K814.82K1.89M
EV to EBITDA-24.477.903.983.28
EV to Sales0.000.160.150.75
EV to Free Cash Flow-2.33-106.752.0511.51
EV to Operating Cash Flow-2.74-106.752.0511.51
Tangible Book Value Per Share-0.19-0.31-0.19-1.16
Shareholders’ Equity Per Share-0.19-0.31-0.19-1.16
Tax and Other Ratios
Effective Tax Rate0.000.000.000.00
Revenue Per Share0.003.533.621.80
Net Income Per Share-0.06-0.100.920.30
Tax Burden1.001.001.001.00
Interest Burden1.461.451.000.79
Research & Development to Revenue0.000.000.000.00
SG&A to Revenue0.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.00
Income Quality5.420.050.300.39

Currency in USD